Published • loading... • Updated
J&J to Refund Covered Entities, Amgen Announces NDC Changes
Summary by 340breport.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
J&J to Refund Covered Entities, Amgen Announces NDC Changes
A New Jersey-based pharmaceutical giant recently announced refunds to 340B covered entities that purchased certain medications in 2023, while a A New Jersey-based pharmaceutical giant recently announced refunds to 340B covered entities that purchased certain medications in 2023, while a California-based drugmaker notified providers of national drug code (NDC) changes for two products.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
